Effects of deregulated Raf and MEK 1 expression on the cytokine- dependency of hematopoietic cells

Advances in Enzyme Regulation

Volumn 40, Issue 1, 2000, Pages 305-337

  McCubrey, James A ^a   Steelman, Linda S ^a   Moye, Phillip W ^a   Hoyle, Paul E ^a   Weinstein Oppenheimer, Caroline ^a,b   Chang, Fumin ^a   Pearce, Marianne ^a   White, Martyn K ^a,c   Franklin, Richard ^a   Blalock, William L ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSIDAD DE VALPARAÍSO   (Chile)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 3; JANUS KINASE; MEK1 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PRIMER DNA; PROTEIN BCL 2; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN;

ANIMAL; ANIMAL CELL; CELL LINE; CELL PROLIFERATION; CONFERENCE PAPER; CYTOLOGY; DNA FLANKING REGION; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INDUCTION; GENE REPRESSION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; METABOLISM; MOUSE; NONHUMAN; PHYSIOLOGY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALIA; JANUS; MURINAE;

EID: 0034130788     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(99)00033-3     Document Type: Conference Paper

References (102)

1. W. L. BLALOCK, C. WEINSTEIN-OPPENHEIMER, F. CHANG, P. E. HOYLE, X. Y. WANG, P. A. ALGATE, R. A. FRANKLIN, S. M. OBERHAUS, L. S. STEELMAN and J. A. MCCUBREY, Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: sites for intervention with anti-neoplastic drugs, Leukemia 13, 1109-1166 (1999).
2. X. Y. WANG, L. S. STEELMAN and J. A. MCCUBREY, Abnormal activation of cytokine gene expression by intracisternal type A particle transposition: Effects of mutations which result in autocrine growth factor stimulation and malignant transformation, Cytok. & Mol. Ther. 3, 1-19 (1997).
3. X. Y. WANG and J. A. MCCUBREY, Regulation of interleukin 3 expression in normal and autocrine transformed hematopoietic cells, Int. J. Oncol. 10, 989-1001 (1997).
4. X. Y. WANG and J. A. MCCUBREY, Differential effects of retroviral long terminal repeats on interleukin 3 gene expression and autocrine transformation, Leukemia 11, 1711-1725 (1997).
5. J. A. MCCUBREY, L. S. STEELMAN, P. E. HOYLE, W. L. BLALOCK, C. WEINSTEIN-OPPENHEIMER, R. A. FRANKLIN, H. CHERWINSKI, E. BOSCH and M. MCMAHON, Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells, Leukemia 12, 1903-1929 (1998).
6. P. E. HOYLE, L. S. STEELMAN and J. A. MCCUBREY, Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony-stimulating factor gene, Cytok. Cell. Mol. Ther. 3, 159-168 (1997).
7. P. A. ALGATE, L. S. STEELMAN, M. W. MAYO, A. MIYAJIMA and J. A. MCCUBREY, Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line, Blood 83, 2450-2468 (1994).
8. L. S. STEELMAN, P. A. ALGATE, W. L. BLALOCK, X. Y. WANG, K. D. PREVOST, P. E. HOYLE and J. A. MCCUBREY, Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells, Leukemia 10, 528-542 (1996).
9. T. M. DEXTER, J. GARLAND, D. SCOTT, E. SCOLNICK and D. METCALF, Growth factor-dependent hemopoietic precursor cell lines, J. Exp. Med. 152, 1036-1047 (1980).
10. T. KITAMURA, T. TANGE, T. TERASAWA, S. CHIBA, T. KUWAKI, K. MIYAGAWA, Y. F. PIAO, K. MIYAZONO, A. URABE and F. TAKAKU, Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3 or erythropoietin, J. Cell. Physiol. 140, 323-334 (1989).
11. J. P. MCKEARN, J. A. MCCUBREY and B. FAGG, Enrichment of hematopoietic precursor cells and cloning of multipotential B lymphocyte precursors, Proc. Natl. Acad. Sci. USA 82, 7414-7418 (1985).
12. J. A. MCCUBREY, G. HOLLAND, J. MCKEARN and R. RISSER, Abrogation of factor-dependence in 2 IL-3-dependent cell lines can occur by two distinct mechanisms, Oncogene Res. 4, 97-109 (1989).
13. J. A. MCCUBREY, S. R. SMITH, P. A. ALGATE, J. E. DEVENTE, M. K. WHITE and L. S. STEELMAN, Retroviral infection can abrogate the factor-dependency of hematopoietic cells by autocrine and non-autocrine mechanisms depending on the presence of a functional viral oncogene, Oncogene 8, 2905-2915 (1993).
14. J. A. MCCUBREY, L. S. STEELMAN, X. Y. WANG, E. W. DAVIDIAN, P. E. HOYLE, C. WHITE, K. D. PREVOST, P. A. ALGATE, P. ROBBINS, D. MYLOTT and M. K. WHITE, Autocrine growth factor secretion after transformation of human cytokine dependent cells by viral and cellular oncogenes, Int. J. Oncol. 7, 573-586 (1995).
15. J. A. MCCUBREY, L. S. STEELMAN, X. Y. WANG, P. A. ALGATE, P. E. HOYLE, C. WHITE, E. W. DAVIDIAN, K. D. PREVOST, P. ROBBINS, D. MYLOTT and M. K. WHITE, Differential effects of viral and cellular oncogenes on the growth factor-dependency of hematopoietic cells, Int. J. Oncol. 7, 295-310 (1995).
16. M. URASHIMA, G. TEOH, D. CHAUHAN, A. OGATA, S. SHIRAHAMA, C. KAIHARA, M. MATSUZAKI, H. MATSUSHIMA, M. AKIYAMA, Y. YUZA, K. MAEKAWA and K. C. ANDERSON, MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells, Blood 92, 959-967 (1998).
17. J. C. WINKELMANN, J. WARD, P. MAYEUX, C. LACOMBE, L. SCHIMMENTI and R. B. JENKINS, A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein, Blood 85, 179-185 (1995).
18. J. N. IHLE, B. A. WITTHUHN, F. W. QUELLE, K. YAMAMOTO and O. SILVENNOINEN, Signaling through the hematopoietic cytokine receptors, Annu. Rev. Immunol. 13, 369-399 (1995).
19. N. SATO, K. SAKAMAKI, N. TERADA, K. ARAI and A. MIYAJIMA, Critical cytoplasmic domains of the common beta subunit responsible for differentiation, EMBO J. 12, 4181-4189 (1993).
20. T. KINOSHITA, T. YOKOTA, K. ARAI and A. MIYAJIMA, Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors, EMBO J. 14, 266-275 (1995).
21. E. YANG and S. J. KORSMEYER, Molecular thanatopsis: a discourse on the BCL2 family and cell death, Blood 88, 386-401 (1995).
22. T. F. GAJEWSKI and C. B. THOMPSON, Apoptosis meets signal transduction: elimination of a bad influence, Cell 87, 589-592 (1996).
23. M. J. FERNANDEZ-SARABIA and J. R. BISCHOFF, Bcl-2 associates with the ras-related protein R-ras p23, Nature 366, 274-275 (1993).
24. Ras in Ras-induced apoptosis, J. Biol. Chem. 271, 2376-2379 (1996).
25. H. G. WANG, T. MIYASHITA, S. TAKAYAMA, T. SATO, T. TORIGOE, S. KRAJEWSKI, S. TANAKA, L. HOVEY, III, J. TROPPMAIR, U. R. RAPP and J. C. REED, Apoptosis regulation by interaction of Bcl-2 and Raf-1 kinase, Oncogene 9, 2751-2756 (1994).
26. H. G. WANG, S. TAKAYAMA, U. R. RAPP and J. C. REED, Bcl-2 interacting protein, Bag-1 binds to and activates the kinase Raf-1, Proc. Natl. Acad. Sci. USA 93, 7063-7068 (1996).
27. H. G. WANG, U. R. RAPP and J. C. REED, Bcl-2 targets the protein kinase Raf-1 to mitochondria, Cell 87, 629-638 (1996).
28. L and Bcl-2 displaces Bax and promotes cell death, Cell 80, 285-291 (1995).
29. L, Cell 87, 619-628 (1996).
30. P. SAHARINEN, J. PIERCE, C. J. MARSHALL, T. STURGILL, D. S. FINBLOOM and A. C. LARNER, Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway, Mol. Cell. Biol. 17, 3833-3840 (1997).
31. M. SAKATSUME, L. F. STANCATO, M. DAVID, O. SILVENNOINEN, P. SAHARINEN, J. PIERCE, A. C. LARNER and D. S. FINBLOOM, Interferon gamma activation of Raf-1 is Jak1-dependent and p21ras-independent, J. Biol. Chem. 273, 3021-3026 (1998).
32. D. MORRISON, Mechanisms regulating Raf-1 activity in signal tranduction pathways, Mol. Repro. & Dev. 42, 507-514 (1995).
33. G. E. MARK, I. R. MAC, M. E. DIGAN, L. AMBROSIO and N. PERRIMON, Drosophila melanogaster homologs of the raf oncogene, Mol. Cell. Biol. 7, 2134-2140 (1987).
34. S. M. STORM, U. BRENNSCHEIDT, G. SITHANANDAM and U. R. RAPP, Raf oncogenes in carcinogenesis, Crit. Rev. Oncog. 2, 1-8 (1990).
35. K. W. MUSZYNSKI, F. W. RUSCETTI, G. HEIDECKER, U. RAPP, U. TROPPMAIR, J. M. GOOYA and J. R. KELLER, Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells, J. Exp. Med. 181, 2189-2199 (1995).
36. C. A. PRITCHARD, L. BOLIN, R. SLATTERY, R. L. MURRAY and M. MCMAHON, Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase, Current Biology 6, 614-617 (1996).
37. L. WOJNOWSKI, A. M. ZIMMER, T. W. BECK, H. HAHN, R. BERNAL, U. R. RAPP and A. ZIMMER, Endothelial apoptosis in Braf-deficient mice, Nature Gen. 16, 293-297 (1997).
38. L. WOJNOWSKI, L. F. STANCATO, A. M. ZIMMER, H. HAHN, T. W. BECK, A. C. LARNER, U. R. RAPP and A. ZIMMER, C-raf-1 protein kinase is essential for mouse development, Mechanisms of Development 76, 141-149 (1998).
39. V. P. STANTON, D. W. NICHOLS, A. P. LAUDANO and G. M. COOPER, Definition of the human raf amino-terminal regulatory region by deletion mutagenesis, Mol. Cell. Biol. 9, 639-647 (1989).
40. M. L. SAMUELS, M. J. WEBER, J. M. BISHOP and M. MCMAHON, Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase, Mol. Cell. Biol. 13, 6241-6252 (1993).
41. C. A. PRITCHARD, M. L. SAMUELS, E. BOSCH and M. MCMAHON, Conditionally oncogenic forms of the A-raf and B-raf protein kinases display different biological and biochemical properties in NIH 3T3 cells, Mol. Cell. Biol. 15, 9430-9442 (1995).
42. E. BOSCH, H. CHERWINSKI, D. PETERSON and M. MCMAHON, Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1, Oncogene 11, 1021-1034 (1997).
43. J. R. FABIAN, I. O. DAAR and D. K. MORRISON, Critical tyrosine residues regu-late the enzymatic and biological activity or raf-1 kinase, Mol. Cell. Biol. 13, 7170-7179 (1993).
44. R. MARAIS, Y. LIGHT, H. PATERSON and C. J. MARSHALL, Ras recruits raf-1 to the plasma membrane for activation by tyrosine phosphorylation, EMBO J. 14, 101-110 (1995).
45. A. D. CATLING, C. W. M. REUTER, M. E. COX, S. J. PARSONS and M. J. WEBER, Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain, J. Biol. Chem. 269, 30,014-30,021 (1994).
46. C. W. REUTER, A. D. CATLING, T. JELINEK and M. J. WEBER, Biochemical analysis of MEK activation in NIH-3T3 fibroblasts. Identification of B-raf and other activators, J. Biol. Chem. 270, 7644-7655 (1995).
47. R. K. JAISWAL, S. A. MOODIE, A. WOLFMAN and G. E. LANDRETH, The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras, Mol. Cell. Biol. 14, 6944-6953 (1994).
48. S. J. MANSOUR, W. T. MATTEN, A. S. HERMANN, J. M. CANDIA, S. RONG, K. FUKASAWA, G. F. VANDER WOUDE and N. G. AHN, Transformation of mammalian cells by constitutively active MAP kinase kinase, Science 265, 966-970 (1994).
49. W. HUANG, D. S. KESSLER and R. L. ERIKSON, Biochemical and biological analysis of MEK1 phosphorylation site mutants, Mol. Biol. Cell. 15, 237-245 (1995).
50. A. BRUNET, G. PAGES and J. POUYSSEGUR, Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts, Oncogene 9, 3379-3387 (1994).
51. E. G. KREBS, R. SEGE, D. SEGER, A. A. RESZKA, E. S. MUNAR, H. ELDARFINKELMAN, G. DOBROWOLSKA, A. M. JENSEN, J. S. CAMPBELL and E. H. FISCHER, Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII, J. Biol. Chem. 269, 25,699-25,709 (1994).
52. A. ALESSANDRINI, H. GREULICH, W. HUANG and R. L. ERIKSON, MEK1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells, J. Biol. Chem. 271, 31,612-31,618 (1996).
53. R. J. DAVIS, Transcriptional regulation by MAP kinases, Mol. Repro. & Del. 42, 459-467 (1995).
54. S. HIBI, J. LÖHLER, J. FRIEL, C. STOCKING and W. OSTERTAG, Induction of monocytic differentiation and tumorigenicity by v-Ha-ras in differentiation-arrested hematopoietic cells, Blood 81, 1841-1848 (1993).
55. A. P. K. NAIR, I. D. DIAMANTIS, J. F. CONSCIENCE, V. KINDLER, P. HOFER and C. MORONI, A v-Ha-ras dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production, Mol. Cell. Biol. 9, 1183-1190 (1989).
56. U. R. RAPP, J. TROPPMAIR, M. CARROLL and W. S. MAY, Role of raf-1 protein kinase in IL-3 and GM-CSF mediated signal transduction, Curr. Top. Microbiol. Immunol. 166, 129-139 (1990).
57. J. L. CLEVELAND, J. TROPPMAIR, G. PACKHAM, D. S. ASKEW, P. LLOYD, M. GONZALEZ-GARCIA, G. NUÑEZ, J. N. IHLE and U. R. RAPP, v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells, Oncogene 9, 2227-2233 (1994).
58. G. ROVERA, M. VALTIERI, F. MAVILIO and E. P. REDDY, Effect of Abelson murine leukemia virus on granulocytic differentiation and interleukin-3 dependence of a murine progenitor cell line, Oncogene 1, 29-35 (1987).
59. J. A. MCCUBREY and L. S. STEELMAN, Viral models for understanding chronic myelogenous leukemia, pp. 137-152 in Hematology/Chronic Myelogenous Leukemia. (A. B. DEISSEROTH and R. B. ARLINGHAUS eds.). Vol. 13. Marcel Dekker Inc, New York, NY (1991).
60. W. D. COOK, D. METCALF, N. A. NICOLA, A. W. BURGESS and F. WALKER, Malignant transformation of a growth factor-dependent myeloid cell line by Abelson virus without evidence of an autocrine mechanism, Cell 41, 677-683 (1985).
61. J. H. PIERCE, P. P. DI FIORE , S. A. AARONSON, M. POTTER, J. PUMPHREY, A. SCOTT and J. N. IHLE, Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism, Cell 41, 685-693 (1985).
62. B. MATHEY-PREVOT, G. NABEL, R. PALACIOS and D. BALTIMORE, Abelson virus abrogation of interleukin-3 dependence in a lymphoid cell line, Mol. Cell. Biol. 6, 4133-4135 (1986).
63. E. T. KIPREOS and J. Y. WANG, Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene, Oncogene Res. 2, 277-284 (1988).
64. J. H. PIERCE, M. RUGGIERO, T. P. FLEMING, P. P. DIFIORE, J. S. GREENBERGER, L. VARTICOVSKI, J. SCHLESSINGER, G. ROVERA and S. A. AARONSON, Signal transduction through the EGF receptor transfected into IL-3-dependent hematopoietic cells, Science 239, 628-631 (1988).
65. J. A. MCCUBREY, L. S. STEELMAN, M. W. MAYO, P. A. ALGATE, R. A. DELLOW and M. KALEKO, Growth promoting effects of insulin-like growth factor-1 on hematopoietic cells: Overexpression of introduced IGF-1 receptor abrogates IL-3-dependency of murine factor dependent cells by a ligand-dependent mechanism, Blood 78, 921-929 (1991).
66. Y. SHOUNAN, M. MILLER and G. SYMONDS, Transformation of FDC-P1 cells to IL-3 independence by a murine retrovirus containing v-erb-B, Exp. Hematol. 23, 492-499 (1995).
67. M. MILLER, A. KENNEWELL, Y. TAKAYAMA, A. BRUSKIN, J. M. BISHOP, G. JOHNSON and G. SYMONDS, Transformation of early erythroid precursor cells (BFU-E) by a recombinant murine retrovirus containing v-erb-B, Oncogene 5, 1125-1131 (1990).
68. E. F. WHEELER, D. ASKEW, S. MAY, J. N. IHLE and C. J. SHEER, The v-fms oncogene induces factor-independent growth and transformation of the interleukin-3-dependent myeloid cell line FDC-P1, Mol. Cell. Biol. 7, 1673-1680 (1987).
69. L. R. ROHRSCHNEIDER and D. METCALF, Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells, Mol. Cell. Biol. 9, 5081-5092 (1989).
70. S. M. ANDERSON, D. M. CAROL and F. D. LEE, Abrogation of IL-3 dependent growth requires a functional v-src gene product: evidence for an autocrine growth cycle, Oncogene 5, 317-325 (1990).
71. R. W. OVERELL, J. D. WATSON, B. GALLIS, K. E. WEISSER, D. COSMAN and M. B. WIDMER, Nature and specificity of lymphokine independence induced by a selectable retroviral vector expressing v-src, Mol. Cell. Biol. 7, 3394-3401 (1987).
72. K. A. MECKLING-GILL, S. P. YEE, J. W. SCHRADER and T. PAWSON, A retrovirus encoding the v-fps protein-tyrosine kinase induces factor-independent growth and tumorigenicity in FDC-P1 cells, Biochim. Biophys. Acta 1137, 65-72 (1992).
73. N. UEMURA, K. OZAWA, A. TOJO, K. TAKAHASHI, A. OKANO, H. KARASUYAMA, K. TANI and S. ASANO, Acquisition of interleukin-3 independence in FDC-P2 cells after transfection with the activated c-H-ras gene using a bovine papillomavirus-based plasmid vector, Blood 80, 3198-3204 (1992).
74. G. Q. DALEY and D. BALTIMORE, Transformation of an interleukin-3 dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 BCR-ABL protein, Proc. Natl. Acad. Sci. USA 85, 9312-9315 (1988).
75. I. K. HARIHARAN, J. M. ADAMS and S. CORY, Bcr-ab1 oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia, Oncogene Res. 3, 387-399 (1988).
76. E. SPOONCER, L. FAIRBAIRN, G. J. COWLING, T. M. DEXTER, A. D. WHETTON and P. J. OWEN-LYNCH, Biological consequences of p60v-ab1 protein tyrosine kinase activity in a primitive, multipotent haemopoietic cell line, Leukemia 8, 620-630 (1994).
77. J. H. KABAROWSKI, P. B. ALLEN and L. M. WIEDEMANN, A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells, EMBO J. 13, 5887-5895 (1994).
78. M. TAKAHASHI, T. FURUKAWA, I. TANAKA, Y. OHSAWA, K. NIKKUNI, A. OAKI, T. GOTO, T. HAHIMOTO, K. KISHI and T. KOIKE, Transfection of the bcr/ab1 oncogene into factor-dependent cells by electroporation: acquisition of autonomous proliferation, Hematological Oncol. 12, 53-60 (1994).
79. P. LANEUVILLE, N. HEISTERKAMP and J. GROFFEN, Expression of the chronic myelogenous leukemia-associated p20bcr/ab1 oncoprotein in a murine IL-3 dependent myeloid cell line, Oncogene 6, 275-282 (1991).
80. P. LANEUVILLE, G. SUN, M. TIMM and M. VEKEMANS, Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr/ab1, Blood 80, 1788-1797 (1992).
81. K. OKUDA, T. R. GOLUB, D. G. GILLILAND and J. D. GRIFFIN, p210BCR/ ABL, p190/BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cells, Oncogene 13, 11,147-11,152 (1996).
82. T. R. GOLUB, A. GOGA, G. F. BARKER, D. E. AFAR, J. MCLAUGHLIN, S. K. BOHLANDER, J. D. ROWLEY, O. N. WITTE and D. G. GILLILAND, Oligomerization of the ab1 tyrosine kinase by the Ets protein TEL in human leukemia, Mol. Cell. Biol. 16, 4107-4116 (1996).
83. V. LACRONIQUE, A. BOUREUX, V. D. VALLE, H. POIREL, C. T. QUANG, M. MAUCHAUFFE, C. BERTHOU, M. LESSARD, R. BERGER, J. GHYSDAEL and O. A. BERNARD, A Tel-Jak2 fusion protein with constitutive kinase activity in human leukemia, Science 278, 1309-1312 (1997).
84. N. N. DANIAL, A. PERNIS and P. B. ROTHMAN, Jak-Stat signaling induced by the v-abl oncogene, Science 269, 1875-1877 (1995).
85. R. L. ILARIA and R. A. VAN ETTEN, p210 and p190 (BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific Stat family members, J. Biol. Chem. 271, 31,704-31,710 (1996).
86. Y. MURAKAMI, S. NAKANO, Y. NIHO, K. HAMASAKI and K. IZUHARA, Constitutive activation of Jak-2 and Tyk-2 in a v-Src-transformed human gallbladder adenocarcinoma cell line, J. Cell. Physiol. 175, 220-228 (1998).
87. G. S. CAMPBELL, C. L. YU, R. JOVE and C. CARTER-SU, Constitutive activation of JAK1 in Src-transformed cells, J. Biol. Chem. 272, 2591-2594 (1997).
88. G. R. PERKINS, C. J. MARSHALL and M. K. L. COLLINS, The role of MAP kinase in interleukin-3 stimulation of proliferation, Blood 87, 3669-3675 (1996).
89. G. NÛNEZ, L. LONDON, D. HOCKENBERY, M. ALEXANDER, J. P. MCKEARN and S. J. KORSMEYER, Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines, J. Immunol. 144, 3602-3610 (1990).
90. A. D. MILLER and C. J. ROSMAN, Improved retroviral vectors for gene transfer and expression, Biotechniques 7, 980-990 (1989).
91. J. P. MORGENSTERN and H. LAND, Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line, Nucleic Acid Res. 18, 3587-3596 (1990).
92. D. T. DUDLEY, L. PUNG, S. J. DECKER, A. J. BRIDGES and A. R. SALTIEL, A synthetic inhibitor of the mitogen-activated protein kinases cascade, Proc. Natl. Acad. Sci. USA 92, 7686-7689 (1995).
93. D. C. YOUNG and J. D. GRIFFIN, Autocrine secretion of GM-CSF in acute myeloblastic leukemia, Blood 68, 1178-1181 (1986).
94. C. SIRARD, P. LANEUVILLE and J. E. DICK, Expression of bcr-ab1 abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism, Blood 83, 1575-1585 (1994).
95. J. A. MCCUBREY, L. S. STEELMAN, G. SANDLIN, R. S. RIDDLE and D. K. WAYS, Effects of phorbol esters on an interleukin-3-dependent cell line, Blood 76, 63-72 (1990).
96. J. A. MCCUBREY, L. S. STEELMAN and J. P. MCKEARN, Interleukin-3 and phorbol esters induce different patterns of immediate-early gene expression in an interleukin-3-dependent cell line, Oncogene Res. 6, 1-12 (1991).
97. D. K. WAYS, W. QIN, R. S. RIDDLE, T. D. GARRIS, T. E. BENNETT, L. S. STEELMAN and J. A. MCCUBREY, Differential effect of phorbol esters and IL-3 on protein kinase C isoform content and kinase activity in the FDC-P1 cell line, Blood 78, 2633-2641 (1991).
98. S. A. MCCARTHY, M. L. SAMUELS, C. A. PRITCHARD, J. A. ABRAHAM and M. MCMAHON, Rapid induction of heparin binding epidermal growth factor/diphteria toxic receptor by Raf and Ras oncogenes, Genes Dev. 9, 1953-1964 (1994).
99. A. SEWING, B. WISEMAN, A. C. LLOYD and H. LAND, High-intensity Raf causes cell cycle arrest mediated by p21Cip1, Mol. Cell. Biol. 17, 5588-5597 (1997).
100. K. M. PUMIGLIA and S. J. DECKER, Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway, Proc. Natl. Acad. Sci. USA 94, 448-452 (1997).
101. C. LLOYD, F. OBERMULLER, S. STADDON, C. F. BARTH, M. MCMAHON and H. LAND, Cooperating oncogenes converge to regulate cyclin/cdk complexes, Genes & Dev. 11, 663-667 (1997).
102. Cip, Mol. Cell. Biol. 17, 5598-5611 (1997).